Peroxisome Proliferator-Activated ReceptorαPlays an Important Role in the Expression of Monocyte Chemoattractant Protein-1 and Neointimal Hyperplasia after Vascular Injury
Author(s) -
Peng Yu,
Qiang Li,
Lu Zhang,
Ming Bai,
Zheng Zhang
Publication year - 2012
Publication title -
ppar research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 49
eISSN - 1687-4765
pISSN - 1687-4757
DOI - 10.1155/2012/970525
Subject(s) - neointimal hyperplasia , monocyte , peroxisome proliferator activated receptor , receptor , vascular smooth muscle , inflammation , activator (genetics) , knockout mouse , chemotaxis , chemokine , ccr2 , medicine , peroxisome , endocrinology , chemistry , cancer research , chemokine receptor , restenosis , smooth muscle , stent
Peroxisome proliferator-activated receptor α is a member of the nuclear receptor superfamily. It modulates smooth muscle cell proliferation and inflammatory cytokines in vitro. In this study, we tested the hypothesis that PPAR α would decrease the expression of monocyte chemoattractant protein-1 and tissue factor, and inhibit neointimal formation in a murine double carotid artery injury model. Carotid artery injury was performed in the PPAR α knockout and wild type (WT) mice, treated and untreated with Wy14643, a PPAR α activator. Up-regulated MCP-1 and TF expression and more neointimal formation were observed in the PPAR α −/− mice compared with WT mice. The activation of PPAR α resulted in further decreased neointimal formation. Our data further suggest that the decrease in neointimal formation is due to down-regulation of MCP-1 by PPAR α resulting in decreased leukocyte infiltration and TF expression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom